CHDI 2024 – SPK-10001 Preclinical Poster
CHDI 2024 – SPK-10001 Preclinical Poster Download File
EAHAD 2024 – Durability in Mice Poster
EAHAD 2024 Poster:Analysis of Long-Term Expression Up To 72 Weeks of a Liver-Specific rAAV Gene Therapy Expressing the Human FVIII Transgene from Dirloctocogene Samoparvovec in Adult Mice Powered By EmbedPress
EAHAD 2024 – OSA Poster
EAHAD 2024 Poster:One Stage Assay Analysis Demonstrates that Gene Therapy-Derived Factor VIII (FVIII) from Dirloctocogene Samoparvovec Reduced Clot Times Compared to Endogenous FVIII at Comparable FVIII Levels Powered By EmbedPress
Spark Demo Post 1
Add Your Heading Text Here Download FIle
NHF 2023 Video: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants
NHF 2023 Video: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants https://sparktherapeuticscongresses.com/uploads/2023/08/NHF-2023-HIV_HCV-poster-video_FINAL.mp4 Download FIle
NHF 2023 Poster: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants
NHF 2023 Poster: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants Download FIle
NHF 2023 Video: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011)
NHF 2023 Video: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011) https://sparktherapeuticscongresses.com/uploads/2023/08/NHF-QoL-poster-video_FINAL.mp4 Download FIle
NHF 2023 Poster: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011)
NHF 2023 Poster: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011) Download FIle
NHF 2023 Video: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial
NHF 2023 Video: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial https://sparktherapeuticscongresses.com/uploads/2023/08/NHF-2023-SPK-8011-poster-video_FINAL.mp4 Download FIle
NHF 2023 Poster: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial
NHF 2023 Poster: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial Download FIle